patent/WO-0016797-A3

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f4e2acc1c69165d6defd329fc3256ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
filingDate	1999-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_426b8be424aa44ea36a03ab18f9d0350
publicationDate	2000-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-0016797-A3
titleOfInvention	Use of glp-1 or analogs in treatment of stroke
abstract	This invention provides a method of reducing mortality and morbidity associated with stroke. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.
priorityDate	1998-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5631224-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9929336-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9808873-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9808531-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16186314 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396684

Total number of triples: 25.